BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19747852)

  • 1. Pathology of late-onset anthracycline cardiomyopathy.
    Bernaba BN; Chan JB; Lai CK; Fishbein MC
    Cardiovasc Pathol; 2010; 19(5):308-11. PubMed ID: 19747852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy.
    Pinarli FG; Oğuz A; Tunaoğlu FS; Karadeniz C; Gökçora N; Elbeg S
    Pediatr Blood Cancer; 2005 Apr; 44(4):370-7. PubMed ID: 15602715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthracycline-induced cardiomyopathy.
    Simmons A; Vacek JL; Meyers D
    Postgrad Med; 2008 Nov; 120(4):67-72. PubMed ID: 19020367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of afterload reduction in the prevention of late anthracycline cardiomyopathy.
    Silber JH
    Pediatr Blood Cancer; 2005 Jun; 44(7):607-13. PubMed ID: 15795884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery from anthracycline cardiomyopathy--how can it be explained?
    Christiansen S
    J Heart Lung Transplant; 2009 Jul; 28(7):751. PubMed ID: 19560709
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of mtDNA lesions in anthracycline cardiotoxicity.
    Lebrecht D; Walker UA
    Cardiovasc Toxicol; 2007; 7(2):108-13. PubMed ID: 17652814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of endomyocardial biopsy to assess anthracycline-induced cardiotoxicity.
    Jones RL; Miles DW
    Lancet Oncol; 2005 Feb; 6(2):67. PubMed ID: 15683815
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer].
    Oberholzer K; Kunz RP; Dittrich M; Thelen M
    Rofo; 2004 Sep; 176(9):1245-50. PubMed ID: 15346258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia: retrospective cohort study in a single centre in the United Kingdom.
    Temming P; Qureshi A; Hardt J; Leiper AD; Levitt G; Ancliff PJ; Webb DK
    Pediatr Blood Cancer; 2011 Apr; 56(4):625-30. PubMed ID: 21298750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic prevention of anthracycline-induced cardiomyopathy.
    Maradia K; Guglin M
    Cardiol Rev; 2009; 17(5):243-52. PubMed ID: 19690476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy.
    Acar Z; Kale A; Turgut M; Demircan S; Durna K; Demir S; Meriç M; Ağaç MT
    J Am Coll Cardiol; 2011 Aug; 58(9):988-9. PubMed ID: 21851890
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
    Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
    Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of anthracycline-induced cardiotoxicity with electrocardiography.
    Horacek JM; Jakl M; Horackova J; Pudil R; Jebavy L; Maly J
    Exp Oncol; 2009 Jun; 31(2):115-7. PubMed ID: 19550402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapeutics-induced heart failure].
    Paulides M; Wojnowski L
    Med Klin (Munich); 2007 Jul; 102(7):574-8. PubMed ID: 17634876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.
    Sieswerda E; Kremer LC; Vidmar S; De Bruin ML; Smibert E; Sjöberg G; Cheung MM; Weintraub RG
    Pediatr Blood Cancer; 2010 Apr; 54(4):579-84. PubMed ID: 20014238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracycline cardiomyopathy monitored by morphologic changes.
    Billingham ME; Mason JW; Bristow MR; Daniels JR
    Cancer Treat Rep; 1978 Jun; 62(6):865-72. PubMed ID: 667860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of myocardial fibrosis in idiopathic cardiomyopathies and chronic Chagasic cardiopathy.
    Rossi MA
    Can J Cardiol; 1991 Sep; 7(7):287-94. PubMed ID: 1933634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexrazoxane for the prevention of cardiomyopathy in anthracycline treated pediatric cancer patients.
    Anderson B
    Pediatr Blood Cancer; 2005 Jun; 44(7):584-8. PubMed ID: 15700251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of exercise in rehabilitation of cancer survivors.
    Braith RW
    Pediatr Blood Cancer; 2005 Jun; 44(7):595-9. PubMed ID: 15747335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.